Ubs Asset Management Americas Inc Madrigal Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 22,356 shares of MDGL stock, worth $7.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,356
Previous 24,609 9.16%
Holding current value
$7.01 Million
Previous $6.89 Million 31.19%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$212.22 - $292.96 $478,131 - $660,038
-2,253 Reduced 9.16%
22,356 $4.74 Million
Q2 2024

Aug 13, 2024
BUY
$193.33 - $291.99 $2.01 Million - $3.03 Million
10,374 Added 72.88%
24,609 $6.89 Million
Q4 2023

Feb 14, 2024
SELL
$120.4 - $237.13 $191,556 - $377,273
-1,591 Reduced 10.05%
14,235 $3.29 Million
Q3 2023

Nov 13, 2023
BUY
$146.04 - $225.78 $51,698 - $79,926
354 Added 2.29%
15,826 $2.31 Million
Q1 2023

May 15, 2023
BUY
$231.06 - $307.08 $3.57 Million - $4.75 Million
15,472 New
15,472 $3.75 Million
Q2 2022

Aug 12, 2022
BUY
$58.04 - $100.2 $244,000 - $421,240
4,204 Added 33.82%
16,634 $1.19 Million
Q2 2021

Aug 16, 2021
BUY
$97.2 - $137.59 $59,000 - $83,517
607 Added 5.13%
12,430 $1.21 Million
Q1 2021

May 14, 2021
BUY
$108.54 - $125.2 $230,321 - $265,674
2,122 Added 21.87%
11,823 $1.38 Million
Q4 2020

Mar 01, 2021
BUY
$110.06 - $133.7 $34,889 - $42,382
317 Added 3.38%
9,701 $1.08 Million
Q3 2020

Nov 13, 2020
BUY
$99.78 - $124.21 $76,730 - $95,517
769 Added 8.93%
9,384 $1.11 Million
Q2 2020

Aug 14, 2020
BUY
$60.13 - $125.71 $302,032 - $631,441
5,023 Added 139.84%
8,615 $975,000
Q1 2020

May 15, 2020
SELL
$66.76 - $93.49 $229,921 - $321,979
-3,444 Reduced 48.95%
3,592 $239,000
Q4 2019

Feb 14, 2020
BUY
$84.28 - $118.5 $281,832 - $396,264
3,344 Added 90.57%
7,036 $641,000
Q3 2019

Nov 14, 2019
BUY
$84.4 - $106.53 $51,990 - $65,622
616 Added 20.03%
3,692 $318,000
Q1 2019

May 14, 2019
BUY
$103.48 - $143.84 $28,560 - $39,699
276 Added 9.86%
3,076 $0
Q4 2018

Feb 13, 2019
SELL
$94.77 - $215.54 $111,165 - $252,828
-1,173 Reduced 29.52%
2,800 $315,000
Q3 2018

Nov 14, 2018
SELL
$207.3 - $300.31 $139,512 - $202,108
-673 Reduced 14.49%
3,973 $0
Q2 2018

Aug 14, 2018
BUY
$101.55 - $313.9 $471,801 - $1.46 Million
4,646 New
4,646 $0

Others Institutions Holding MDGL

# of Institutions
297
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.37B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email